R. I. Freudenthal

464 total citations
21 papers, 354 citations indexed

About

R. I. Freudenthal is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, R. I. Freudenthal has authored 21 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Physiology. Recurrent topics in R. I. Freudenthal's work include Pharmacogenetics and Drug Metabolism (6 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Metabolism and Genetic Disorders (3 papers). R. I. Freudenthal is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Metabolism and Genetic Disorders (3 papers). R. I. Freudenthal collaborates with scholars based in United States. R. I. Freudenthal's co-authors include Monroe E. Wall, Roni Rosenfeld, Joseph T. Martin, H. Dix Christensen, Dolores R. Brine, Colin G. Pitt, F. Ivy Carroll, Charles L. Litterst, Edward G. Mimnaugh and Joseph V. Martin and has published in prestigious journals such as Science, Analytical Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R. I. Freudenthal

21 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. I. Freudenthal United States 9 191 98 71 54 52 21 354
Jean-Pierre Anger France 8 144 0.8× 50 0.5× 34 0.5× 57 1.1× 34 0.7× 28 461
I. M. Nilsson Sweden 10 401 2.1× 163 1.7× 32 0.5× 143 2.6× 31 0.6× 15 469
Agneta Ohlsson Sweden 7 359 1.9× 134 1.4× 18 0.3× 116 2.1× 33 0.6× 8 434
Edith G. Leighty United States 8 109 0.6× 58 0.6× 17 0.2× 42 0.8× 13 0.3× 10 321
Jagat J. Ghosh India 11 89 0.5× 125 1.3× 53 0.7× 18 0.3× 25 0.5× 24 425
Joseph J. McPhillips United States 15 101 0.5× 164 1.7× 58 0.8× 13 0.2× 31 0.6× 25 613
Jingqi Bao United States 8 446 2.3× 218 2.2× 40 0.6× 50 0.9× 36 0.7× 14 665
Ondřej Zendulka Czechia 8 196 1.0× 63 0.6× 82 1.2× 37 0.7× 28 0.5× 28 357
Noriyuki Usami Japan 16 192 1.0× 47 0.5× 44 0.6× 50 0.9× 92 1.8× 27 656
Holly A. Gefroh United States 8 120 0.6× 33 0.3× 48 0.7× 17 0.3× 48 0.9× 10 368

Countries citing papers authored by R. I. Freudenthal

Since Specialization
Citations

This map shows the geographic impact of R. I. Freudenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. I. Freudenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. I. Freudenthal more than expected).

Fields of papers citing papers by R. I. Freudenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. I. Freudenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. I. Freudenthal. The network helps show where R. I. Freudenthal may publish in the future.

Co-authorship network of co-authors of R. I. Freudenthal

This figure shows the co-authorship network connecting the top 25 collaborators of R. I. Freudenthal. A scholar is included among the top collaborators of R. I. Freudenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. I. Freudenthal. R. I. Freudenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryan, Bernadette M., et al.. (2000). Two-Generation Oral (Diet) Reproductive Toxicity Study of Resorcinol Bis-Diphenylphosphate (Fyrolflex RDP) in Rats. International Journal of Toxicology. 19(4). 243–255. 4 indexed citations
2.
Johnson, William D., et al.. (2000). Twenty-Eight Day Nose-Only Inhalation Toxicity Study of Resorcinol Bis-Diphenylphosphate (Fyrolflex RDP) in Rats. International Journal of Toxicology. 19(4). 223–231. 3 indexed citations
3.
Ryan, Bernadette M., et al.. (2000). Developmental Toxicity Study of Orally Administered Resorcinol Bis-Diphenylphosphate (RDP) in Rabbits. International Journal of Toxicology. 19(4). 257–264. 4 indexed citations
4.
Sherwood, Robert, et al.. (2000). Immunotoxicity Evaluation of Resorcinol Bis-Diphenylphosphate (Fyrolflex RDP) in B6C3F1 Mice. International Journal of Toxicology. 19(4). 265–275. 2 indexed citations
5.
Freudenthal, R. I., et al.. (1995). A Reexamination of Recent Publications Suggesting o-Toluidine May Be a Human Bladder Carcinogen. Regulatory Toxicology and Pharmacology. 21(1). 199–202. 4 indexed citations
6.
Sauerhoff, Mitchell W., et al.. (1984). A 6-month dietary toxicity study of acidic sodium aluminium phosphate in beagle dogs. Food and Chemical Toxicology. 22(1). 7–9. 14 indexed citations
7.
Freudenthal, R. I., et al.. (1979). Dietary subacute toxicity of ethylene thiourea in the laboratory rat.. PubMed. 1(1). 147–61. 8 indexed citations
8.
Freudenthal, R. I., et al.. (1976). Comparison of the drug metabolizing enzymes in the liver and kidneys from homozygous nude swiss, heterozygous normal swiss, homozygous normal swiss and dba/2 mice.. The Mouseion at the JAXlibrary (Jackson Laboratory). 2 indexed citations
9.
Litterst, Charles L., et al.. (1976). A comprehensive study of in vitro drug metabolism in several laboratory species.. Drug Metabolism and Disposition. 4(3). 203–207. 41 indexed citations
10.
Freudenthal, R. I., et al.. (1976). Characterization of the hepatic microsomal mixed-function oxidase enzyme system in miniature pigs.. Drug Metabolism and Disposition. 4(1). 25–27. 13 indexed citations
11.
Freudenthal, R. I. & Peter W. Jones. (1976). Carcinogenesis: a comprehensive survey. Volume I. Polynuclear aromatic hydrocarbons: chemistry, metabolism, and carcinogenesis. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 6 indexed citations
12.
Freudenthal, R. I., et al.. (1974). The effect of norethynodrel, norethindrone and ethynodiol diacetate on hepatic microsomal drug metabolism. Pharmacological Research Communications. 6(5). 457–468. 8 indexed citations
13.
Freudenthal, R. I. & F. Ivy Carroll. (1974). Metabolism of Certain Commonly Used Barbiturates. Drug Metabolism Reviews. 2(1). 265–278. 24 indexed citations
14.
Freudenthal, R. I., Joseph V. Martin, Charles E. Cook, & Monroe E. Wall. (1973). Metabolism and distribution of norethynodrel in pregnant and nonpregnant mice. Toxicology and Applied Pharmacology. 24(1). 125–132. 3 indexed citations
15.
Freudenthal, R. I., et al.. (1973). The preparation of stereospecific tritium-labeled reduced nicotinamide adenine dinucleotide phosphate. Analytical Biochemistry. 51(2). 632–636. 5 indexed citations
16.
Freudenthal, R. I., Joseph T. Martin, & Monroe E. Wall. (1972). Distribution of Δ9‐tetrahydrocannabinol in the mouse. British Journal of Pharmacology. 44(2). 244–249. 48 indexed citations
17.
Freudenthal, R. I., Joseph V. Martin, & Monroe E. Wall. (1972). THE WHOLE BODY DISTRIBUTION OF NORETHINDRONE, ETHYNODIOL DIACETATE AND PROGESTERONE IN THE PREGNANT MOUSE. Journal of Pharmacology and Experimental Therapeutics. 182(2). 328–334. 6 indexed citations
18.
Christensen, H. Dix, R. I. Freudenthal, Roni Rosenfeld, et al.. (1971). Activity of Δ 8 - and Δ 9 -Tetrahydrocannabinol and Related Compounds in the Mouse. Science. 172(3979). 165–167. 138 indexed citations
19.
Freudenthal, R. I., et al.. (1971). THE METABOLISM OF ETHYNODIOL DIACETATE BY RAT AND HUMAN LIVER. Journal of Pharmacology and Experimental Therapeutics. 177(2). 468–473. 6 indexed citations
20.
Freudenthal, R. I., et al.. (1971). Metabolism of norethynodrel by rat liver. Biochemical Pharmacology. 20(7). 1507–1512. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026